Navigation Links
Xybion Completes Acquisition of Stelex and Vital-Path, Leaders in Business Process Software and Consulting Services for Regulated Industries, from GE Healthcare
Date:5/12/2010

earch organizations worldwide for end-to-end needs in the pre-clinical R&D, Quality, and Regulatory risk and compliance management solutions. In addition to Pristima™, Pristima™ VM, Providence, eQRP, and eQCM, Xybion also provides professional services, consulting, training and validation activities to clients around the world. Learn more about Xybion at xybion.com.

About Stelex
For over twenty years, Stelex has provided solutions and services to improve business processes for regulated and non-regulated industries, by providing the expertise, strategies and technology to help clients mitigate risk, enhance productivity and increase profitability. Stelex is a client-centered organization, tailoring solutions to address the specific requests and needs of clients. Stelex assists clients in meeting requirements and achieving their business goals. Learn more about Stelex at stelex.com.

###

Read the full story at http://www.prweb.com/releases/Xybion/Stelex/prweb3983884.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management
2. Korea Institute of Toxicology Implementing Xybion's Pristima™
3. Nile Therapeutics Completes Dose Escalation in Ongoing Phase II Study
4. Hendrick Construction Completes Oak Ridge National Laboratory Expansion
5. Oncolytics Biotech(R) Inc. Completes Patient Enrollment in Phase I Portion of U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial
6. Therapeutic Proteins Inc. Completes First Independent, Dedicated Biosimilars Manufacturing Facility in U.S.
7. NOVAVAX Completes Enrollment of Pivotal H1N1 Influenza Vaccine Clinical Trial in Mexico
8. EUSA Pharma Completes Establishment of Commercial Infrastructure With Appointment of President for Europe and International Region
9. APT Pharmaceuticals Completes Enrollment in Phase III for Inhaled Cyclosporine
10. Ocera Therapeutics Completes Phase 2B Enrollment in the ASTUTE Trial
11. Neuralstem Completes $5.25 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)...   Tamir Biotechnology , a leading developer of ... Ebola antiviral therapy program. Clinical Progress ... being evaluated and considered by a number of clinicians ... the first quarter of 2015, the company participated in ... Evaluation of Potential Treatments and Vaccines For Ebola In ...
(Date:4/30/2015)... April 30, 2015 Nitto Avecia, ... announces its increased capacity and production capability to ... client variety and service fulfillment continues to drive ... improve process throughput capacities. , In ... installed downstream process equipment at its Milford, MA ...
(Date:4/30/2015)... Budapest, Hungary (PRWEB) April 30, 2015 ... electronic lab notebook with integrated protocols and specimen ... chemistry software solutions and consulting services for life ... the development of Labguru’s newest feature: chemical structure ... deep domain features for biologists, bio-chemists, and more, ...
(Date:4/30/2015)... MENLO PARK, Calif. , April 30, 2015 /PRNewswire/ ... company in the emerging field of regenerative medicine, today ... operating results on Thursday, May 7, 2015 after the ... host a conference call and webcast on Thursday, May ... Pacific to discuss the results and recent corporate developments. ...
Breaking Biology Technology:Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 2Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 3Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 4Biotechnology Manufacturer Nitto Avecia Expands Capacity to Meet Client Demand 2Labguru Integrates ChemAxon's Marvin JS, to Enhance Functionality for Chemists 2Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 2Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 3
... March 10, 2011 Dyadic International, Inc. (OTC Pink: ... for the year ended December 31, 2010. The financial ... in conjunction with the financial statements, footnotes and independent ... Markets website at www.otcmarkets.com and on Dyadic,s ...
... MYL ) today announced that its subsidiary ... U.S. Food and Drug Administration (FDA) under the President,s ... Drug Application (NDA) for Zidovudine Tablets, 100 mg. The ... Tablets, by ViiV Healthcare. This pediatric antiretroviral (ARV), the ...
... 2011 In the current economic climate, maintaining ... where billing and collections are impacted by staffing ... for laboratories, where patients rarely see or even ... Oral & Maxillofacial Pathology Laboratory (POMPL), many of ...
Cached Biology Technology:Dyadic International Reports 2010 Fiscal Year Financial Results 2Dyadic International Reports 2010 Fiscal Year Financial Results 3Dyadic International Reports 2010 Fiscal Year Financial Results 4Dyadic International Reports 2010 Fiscal Year Financial Results 5Dyadic International Reports 2010 Fiscal Year Financial Results 6Mylan's Matrix Receives FDA Approval Under PEPFAR for Zidovudine Tablets, 100 mg 2Pathology Lab Builds Business Success with Billing Support from Orion HealthCorp 2Pathology Lab Builds Business Success with Billing Support from Orion HealthCorp 3
(Date:3/24/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) has ... Market 2015-2019" report to their offering. ... grow at a CAGR of 23.5 percent over the ... scenario and the growth prospects of the Global Iris ... market size, the report considers the revenue generated from ...
(Date:3/23/2015)... March 23, 2015   HOYOS Labs , a ... today announced that the Company will demonstrate multiple biometrics-based ... and consumers at Connect:ID on March 23 through 25, ... Labs will highlight the IEEE Biometric Open Protocol Standard; ... and enterprise access control system. BOPS was invented by ...
(Date:3/20/2015)... OXFORD, Conn. , March 20, 2015 ... "Company"), a biometric authentication company focused on the growing ... Wocket® smart wallet is one of the products featured ... today, March 20th at 11:00 PM EST on the ... travels to Las Vegas , site ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... Experimental Biology and Medicine (EBM), Dr. Steven R. Goodman, ... and enhancement of the activities of the Society of ... plan, which is strongly supported by the SEBM Council, ... Board, naming Associate Editors from amongst the leaders in ...
... become the first campus on the West Coast to join ... binding trading system to reduce emissions of greenhouse gases. UC ... to join the climate exchange. Joining the CCX is ... and reduce greenhouse gases (GHG). Trading in GHG contracts may ...
... that a picture can be worth a thousand words. This ... function to promote cancer. Researchers at Johns Hopkins have built ... types of cancers. The results, published Dec. 14 in Science, ... lead to cancer progression. Now that we have ...
Cached Biology News:Experimental Biology and Medicine announces expansion into Asia, opens new office 2Experimental Biology and Medicine announces expansion into Asia, opens new office 3UC San Diego begins trading greenhouse gas credits on Chicago Climate Exchange 2Worth a thousand words: Hopkins researchers paint picture of cancer-promoting culprit 2
Alexa Fluor 350/488/594 Filter Set (Semrock Brightline) *mounted* *Zeiss Axio AF...
IC50: 3 ng/ml · Limit of detection: 0.5 ng/ml...
...
Rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and refrigerated within 6 hours, and processed and frozen within 24 hours. The serum is ...
Biology Products: